AR051904A1 - Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r) - Google Patents
Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r)Info
- Publication number
- AR051904A1 AR051904A1 ARP060100168A ARP060100168A AR051904A1 AR 051904 A1 AR051904 A1 AR 051904A1 AR P060100168 A ARP060100168 A AR P060100168A AR P060100168 A ARP060100168 A AR P060100168A AR 051904 A1 AR051904 A1 AR 051904A1
- Authority
- AR
- Argentina
- Prior art keywords
- neuropeptide
- peptides
- receiver
- agonist activity
- obesity
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
La presente se refiere a agonistas del receptor del neuropéptido-2 de la formula: Y-R1-R2-X-R3-R4-R5-R6-R7-R8-R9-R10-R11-R12-R13-R14-NH2, así como sales farmacéuticamente aceptables, derivados y fragmentos de los mismos, donde los sustituyentes son como aquellos discutidos en la especificacion. Estos compuestos, y las composiciones farmacéuticas que las contienen, son utiles para el tratamiento de enfermedades como, por ejemplo, obesidad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64484005P | 2005-01-18 | 2005-01-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051904A1 true AR051904A1 (es) | 2007-02-14 |
Family
ID=36118121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100168A AR051904A1 (es) | 2005-01-18 | 2006-01-16 | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r) |
Country Status (22)
Country | Link |
---|---|
US (1) | US7410949B2 (es) |
EP (1) | EP1844070B1 (es) |
JP (1) | JP4633804B2 (es) |
KR (1) | KR100905380B1 (es) |
CN (1) | CN101107266A (es) |
AR (1) | AR051904A1 (es) |
AT (1) | ATE500268T1 (es) |
AU (1) | AU2006207659B2 (es) |
BR (1) | BRPI0606675A2 (es) |
CA (1) | CA2594423A1 (es) |
DE (1) | DE602006020407D1 (es) |
DK (1) | DK1844070T3 (es) |
ES (1) | ES2359850T3 (es) |
IL (1) | IL184428A0 (es) |
MX (1) | MX2007008614A (es) |
NO (1) | NO20073664L (es) |
PL (1) | PL1844070T3 (es) |
PT (1) | PT1844070E (es) |
RU (1) | RU2383553C2 (es) |
TW (1) | TWI309653B (es) |
WO (1) | WO2006077035A1 (es) |
ZA (1) | ZA200705674B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006324076A1 (en) * | 2005-12-07 | 2007-06-14 | F. Hoffmann-La Roche Ag | Neuropeptide-2 receptor-agonists |
US8299023B2 (en) * | 2008-09-17 | 2012-10-30 | Hoffmann-La Roche Inc. | Neuropeptide-2 receptor (Y-2R) agonists |
BRPI0921230A2 (pt) * | 2008-11-05 | 2018-10-30 | Hoffmann La Roche | agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo. |
JP5767582B2 (ja) * | 2009-07-02 | 2015-08-19 | 武田薬品工業株式会社 | ペプチド及びその用途 |
US20130040877A1 (en) * | 2009-09-18 | 2013-02-14 | Novo Nordisk A/S | Long-acting y2 receptor agonists |
EP2488195A2 (en) * | 2009-10-13 | 2012-08-22 | F. Hoffmann-La Roche AG | Neuropeptide-2 receptor (y-2r) agonists |
RU2600440C3 (ru) | 2010-12-16 | 2021-12-10 | Ново Нордиск А/С | Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты |
US10933120B2 (en) | 2012-03-22 | 2021-03-02 | Novo Nordisk A/S | Compositions of GLP-1 peptides and preparation thereof |
MA37756B1 (fr) | 2012-06-13 | 2018-09-28 | Hoffmann La Roche | Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane |
EP3590940B1 (en) | 2012-09-25 | 2021-06-09 | F. Hoffmann-La Roche AG | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
TWI661835B (zh) | 2013-11-15 | 2019-06-11 | 丹麥商諾佛 儂迪克股份有限公司 | 選擇性pyy化合物及其用途 |
JP6629198B2 (ja) | 2013-11-15 | 2020-01-15 | ノヴォ ノルディスク アー/エス | 35位にβ−ホモアルギニン置換を有するHPYY(1−36) |
MA38982A1 (fr) | 2013-11-26 | 2017-09-29 | Hoffmann La Roche | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl |
CN106103446B (zh) | 2014-03-26 | 2019-07-30 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物 |
MX2016010675A (es) | 2014-03-26 | 2016-11-10 | Hoffmann La Roche | Compuestos condensados de [1,4]diazepina como inhibidores de produccion de la autotaxina (atx) y acido lisofosfatidico (lpa). |
MA41898A (fr) * | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
RU2726777C2 (ru) | 2015-06-12 | 2020-07-15 | Ново Нордиск А/С | Селективные соединения пептида yy и их применения |
CN108026077B (zh) | 2015-09-04 | 2021-11-05 | 豪夫迈·罗氏有限公司 | 苯氧基甲基衍生物 |
MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
MA42923A (fr) | 2015-09-24 | 2021-04-28 | Hoffmann La Roche | Composés bicycliques comme inhibiteurs mixtes de atx/ca |
WO2017050792A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
JP6845230B2 (ja) | 2015-09-24 | 2021-03-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | デュアルatx/ca阻害剤としての新規な二環式化合物 |
MA49879A (fr) | 2017-03-16 | 2020-06-24 | Hoffmann La Roche | Composés hétérocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca |
CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
WO2019106193A1 (en) | 2017-12-01 | 2019-06-06 | University Of Copenhagen | Peptide hormone with one or more o-glycans |
EP3746111B1 (en) | 2018-02-02 | 2023-07-19 | Novo Nordisk A/S | Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant |
EP3800195A1 (en) * | 2019-10-03 | 2021-04-07 | Universitat de Barcelona | Peptide compounds for reducing side effects of cb1 receptor agonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
NZ265452A (en) | 1993-03-29 | 1997-09-22 | Univ Cincinnati | Analogues of peptide yy, dimers and pharmaceutical compositions |
US6017879A (en) * | 1998-04-03 | 2000-01-25 | B.M.R.A. Corporation B.V. | Template associated NPY Y2-receptor agonists |
EP1583549A4 (en) * | 2003-01-17 | 2006-10-04 | Sod Conseils Rech Applic | YY PEPTIDE ANALOGS |
WO2005053726A1 (en) * | 2003-11-25 | 2005-06-16 | Bayer Pharmaceuticals Corporation | Selective neuropeptide y2 receptor agonists |
WO2005077094A2 (en) * | 2004-02-11 | 2005-08-25 | Amylin Pharmaceuticals, Inc. | Pancreatic polypeptide family motifs and polypeptides comprising the same |
-
2006
- 2006-01-10 US US11/328,743 patent/US7410949B2/en not_active Expired - Fee Related
- 2006-01-11 DK DK06700451.5T patent/DK1844070T3/da active
- 2006-01-11 EP EP06700451A patent/EP1844070B1/en not_active Not-in-force
- 2006-01-11 JP JP2007551586A patent/JP4633804B2/ja not_active Expired - Fee Related
- 2006-01-11 PT PT06700451T patent/PT1844070E/pt unknown
- 2006-01-11 DE DE602006020407T patent/DE602006020407D1/de active Active
- 2006-01-11 AT AT06700451T patent/ATE500268T1/de active
- 2006-01-11 PL PL06700451T patent/PL1844070T3/pl unknown
- 2006-01-11 MX MX2007008614A patent/MX2007008614A/es active IP Right Grant
- 2006-01-11 KR KR1020077018848A patent/KR100905380B1/ko not_active IP Right Cessation
- 2006-01-11 BR BRPI0606675-5A patent/BRPI0606675A2/pt not_active Application Discontinuation
- 2006-01-11 WO PCT/EP2006/000161 patent/WO2006077035A1/en active Application Filing
- 2006-01-11 AU AU2006207659A patent/AU2006207659B2/en not_active Ceased
- 2006-01-11 CN CNA2006800025981A patent/CN101107266A/zh active Pending
- 2006-01-11 ES ES06700451T patent/ES2359850T3/es active Active
- 2006-01-11 CA CA002594423A patent/CA2594423A1/en not_active Abandoned
- 2006-01-11 RU RU2007131504/04A patent/RU2383553C2/ru not_active IP Right Cessation
- 2006-01-16 AR ARP060100168A patent/AR051904A1/es active IP Right Grant
- 2006-01-16 TW TW095101606A patent/TWI309653B/zh not_active IP Right Cessation
-
2007
- 2007-07-05 IL IL184428A patent/IL184428A0/en unknown
- 2007-07-10 ZA ZA200705674A patent/ZA200705674B/xx unknown
- 2007-07-17 NO NO20073664A patent/NO20073664L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE602006020407D1 (de) | 2011-04-14 |
KR100905380B1 (ko) | 2009-06-30 |
PL1844070T3 (pl) | 2011-07-29 |
ES2359850T3 (es) | 2011-05-27 |
IL184428A0 (en) | 2007-10-31 |
EP1844070A1 (en) | 2007-10-17 |
ZA200705674B (en) | 2009-08-26 |
WO2006077035A9 (en) | 2006-10-26 |
TWI309653B (en) | 2009-05-11 |
JP2008527017A (ja) | 2008-07-24 |
ATE500268T1 (de) | 2011-03-15 |
PT1844070E (pt) | 2011-05-04 |
US7410949B2 (en) | 2008-08-12 |
MX2007008614A (es) | 2007-09-11 |
DK1844070T3 (da) | 2011-06-14 |
CN101107266A (zh) | 2008-01-16 |
NO20073664L (no) | 2007-09-28 |
AU2006207659B2 (en) | 2009-10-29 |
WO2006077035A1 (en) | 2006-07-27 |
JP4633804B2 (ja) | 2011-02-16 |
KR20070095422A (ko) | 2007-09-28 |
TW200637874A (en) | 2006-11-01 |
AU2006207659A1 (en) | 2006-07-27 |
CA2594423A1 (en) | 2006-07-27 |
RU2383553C2 (ru) | 2010-03-10 |
EP1844070B1 (en) | 2011-03-02 |
RU2007131504A (ru) | 2009-02-27 |
BRPI0606675A2 (pt) | 2009-07-07 |
US20060160742A1 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051904A1 (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r) | |
ECSP088511A (es) | Agonistas del receptor del neuropeptido-2 | |
ECSP088120A (es) | Derivados de piridazinona como agonistas del receptorde la hormona tiroidea | |
CL2008002793A1 (es) | Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras | |
CR10288A (es) | Pirazoles como inhibidores de la 11-beta-hsd1 | |
CR9748A (es) | Derivados de xantina como agonistas selectivos de hm74a | |
CR10489A (es) | Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides | |
CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
CO6390101A2 (es) | Compuestos purina | |
CL2011000544A1 (es) | Compuestos derivados de benzamida n sustituida por heterociclo, ligandos de los receptores cannabinoides; composicion farmaceutica; y su uso para tratar el dolor, entre otras enfermedades. | |
CR8270A (es) | Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo | |
ECSP12011606A (es) | Agonistas de gpr119 | |
CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
PA8805801A1 (es) | Agonistas novedosos de los receptores de glucorticoides | |
UY31570A1 (es) | Derivados de oxadiazol agonistas del receptor s1p1. composiciones farmacéuticas que lo comprenden y procedimientos de preparacion de los mismos | |
UY30640A1 (es) | Compuestos | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
CR11264A (es) | Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
IN2012DN03042A (es) | ||
ECSP13012600A (es) | CO-cristales y Sales de Inhibidores de CCR3 | |
CO6321280A2 (es) | Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
ECSP10010379A (es) | Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |